For the quarter ending 2025-09-30, PRVA had $51,225K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 9,807 | 9,334 |
| Depreciation | 165 | 415 |
| Amortization of intangibles | 2,601 | 4,069 |
| Stock-based compensation | 18,977 | 36,639 |
| Deferred tax expense | 6,666 | 2,671 |
| Accounts receivable | 55,047 | 121,497 |
| Prepaid expenses and other current assets | -18,306 | 21,344 |
| Other non-current assets and right-of-use asset | -1,289 | -1,056 |
| Accounts payable and accrued expenses | 10,369 | -7,687 |
| Provider liability | 37,630 | 81,185 |
| Operating lease liabilities | -409 | -778 |
| Other long-term liabilities | 1,640 | -153 |
| Net cash provided by operating activities | 51,994 | -16,090 |
| Business acquisitions, net of cash acquired | 0 | 89,058 |
| Other | 1,200 | 0 |
| Net cash used in investing activities | -1,200 | -89,058 |
| Proceeds from exercised stock options | 431 | 4,126 |
| Proceeds from non-controlling interest | 0 | 0 |
| Net cash provided by financing activities | 431 | 4,126 |
| Net (decrease) increase in cash and cash equivalents | 51,225 | -101,022 |
| Cash and cash equivalents at beginning of period | 491,149 | - |
| Cash and cash equivalents at end of period | 441,352 | - |
Privia Health Group, Inc. (PRVA)
Privia Health Group, Inc. (PRVA)